BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• 

  Policy

  Listen: JPM2024 Day 1 Highlights

  The BioSpace team is recording from San Francisco as they bring you the the latest highlights from JPM2024.

  January 8, 2024

   · 

  1 min read
• Business

  insitro Hires Chief Medical Officer to Advance Therapeutic Programs Toward the Clinic

  insitro, a machine learning-powered drug discovery and development company, today announced the appointment of S. Michael Rothenberg, M.D., Ph.D., as chief medical officer.

  January 8, 2024

   · 

  4 min read
• Business

  ATEC Announces Record Preliminary Revenue Results for 2023 and 2024 Revenue Guidance

  Alphatec Holdings, Inc. announced today preliminary revenue results for the fourth quarter and full-year ended December 31, 2023, and provided revenue guidance for full-year 2024.

  January 8, 2024

   · 

  4 min read
• Business

  Paragon 28 Announces Preliminary Unaudited Revenue for Fourth Quarter and Full Year 2023

  Paragon 28, Inc. today announced a range of its preliminary unaudited net revenue for the fourth quarter and full year ended December 31, 2023.

  January 8, 2024

   · 

  4 min read
• Biotech Beach

  Compelling Clinical Data Released for Carlsmed’s aprevo® Technology

  Carlsmed announced today that new clinical data on its aprevo ® technology has been published in the Global Spine Journal.

  January 8, 2024

   · 

  1 min read
• Business

  Guardant Health Announces Preliminary Fourth Quarter and Full Year 2023 Results

  Guardant Health Announces Preliminary Fourth Quarter and Full Year 2023 Results.

  January 8, 2024

   · 

  5 min read
• Business

  Adimab Provides Year-End Update on 2023 Partnership Activities

  Adimab, LLC, the global leader in the discovery and engineering of fully human monoclonal and multispecific antibodies, today announced that it entered into partnership agreements with 10 new companies in 2023.

  January 8, 2024

   · 

  5 min read
• Summit Therapeutics Announces Updated Phase II Data for Ivonescimab at 42nd Annual J.P. Morgan Healthcare Conference

  Summit Therapeutics Announces Updated Phase II Data for Ivonescimab at 42nd Annual J.P. Morgan Healthcare Conference

  January 8, 2024

   · 

  14 min read
• Drug Development

  Bayer starts Phase II study NIRVANA to evaluate elinzanetant in women with sleep disturbances associated with menopause

  Bayer, a global leader in women’s healthcare, announced today the expansion of the clinical development program for the investigational compound elinzanetant.

  January 8, 2024

   · 

  10 min read
• Policy

  AAMI and FDA Co-Sponsor Medtech Conference, ‘AAMI and FDA neXus’

  The Association for the Advancement of Medical Instrumentation is delighted to welcome the U.S. Food and Drug Administration as an official co-sponsor of its upcoming medical device standards conference, AAMI and FDA neXus 2024.

  January 8, 2024

   · 

  2 min read